Trust Point Inc. Buys New Shares in Colgate-Palmolive (NYSE:CL)

Trust Point Inc. bought a new stake in Colgate-Palmolive (NYSE:CLFree Report) in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm bought 25,772 shares of the company’s stock, valued at approximately $2,054,000.

Several other hedge funds have also made changes to their positions in CL. Vest Financial LLC raised its position in Colgate-Palmolive by 25.1% in the fourth quarter. Vest Financial LLC now owns 370,071 shares of the company’s stock worth $29,498,000 after purchasing an additional 74,337 shares in the last quarter. Central Bank & Trust Co. increased its holdings in shares of Colgate-Palmolive by 22.1% during the fourth quarter. Central Bank & Trust Co. now owns 1,383 shares of the company’s stock worth $110,000 after buying an additional 250 shares in the last quarter. Dynamic Advisor Solutions LLC increased its holdings in shares of Colgate-Palmolive by 9.2% during the fourth quarter. Dynamic Advisor Solutions LLC now owns 10,808 shares of the company’s stock worth $864,000 after buying an additional 910 shares in the last quarter. Sarasin & Partners LLP increased its holdings in shares of Colgate-Palmolive by 1.2% during the fourth quarter. Sarasin & Partners LLP now owns 4,053,634 shares of the company’s stock worth $323,115,000 after buying an additional 49,980 shares in the last quarter. Finally, Cornerstone Wealth Management LLC increased its holdings in shares of Colgate-Palmolive by 2.5% during the fourth quarter. Cornerstone Wealth Management LLC now owns 7,170 shares of the company’s stock worth $571,000 after buying an additional 172 shares in the last quarter. Institutional investors own 80.41% of the company’s stock.

Colgate-Palmolive Trading Down 0.9 %

Shares of NYSE:CL traded down $0.84 during trading on Wednesday, reaching $88.22. The stock had a trading volume of 961,257 shares, compared to its average volume of 4,589,521. The firm’s fifty day moving average is $86.23 and its 200 day moving average is $79.56. The company has a debt-to-equity ratio of 8.59, a quick ratio of 0.71 and a current ratio of 1.11. Colgate-Palmolive has a 52 week low of $67.62 and a 52 week high of $90.37. The stock has a market cap of $72.52 billion, a price-to-earnings ratio of 32.05, a P/E/G ratio of 3.39 and a beta of 0.42.

Colgate-Palmolive (NYSE:CLGet Free Report) last issued its earnings results on Friday, January 26th. The company reported $0.87 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.85 by $0.02. Colgate-Palmolive had a net margin of 11.82% and a return on equity of 509.75%. The business had revenue of $4.95 billion for the quarter, compared to analyst estimates of $4.89 billion. During the same period in the prior year, the firm earned $0.77 earnings per share. Colgate-Palmolive’s revenue was up 6.9% on a year-over-year basis. As a group, equities analysts forecast that Colgate-Palmolive will post 3.49 EPS for the current fiscal year.

Colgate-Palmolive Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, May 15th. Shareholders of record on Monday, April 22nd will be paid a $0.50 dividend. This represents a $2.00 dividend on an annualized basis and a dividend yield of 2.27%. This is a positive change from Colgate-Palmolive’s previous quarterly dividend of $0.48. The ex-dividend date is Friday, April 19th. Colgate-Palmolive’s dividend payout ratio (DPR) is 69.06%.

Insider Buying and Selling at Colgate-Palmolive

In other news, insider Jennifer Daniels sold 61,633 shares of the stock in a transaction dated Thursday, February 1st. The shares were sold at an average price of $83.93, for a total value of $5,172,857.69. Following the completion of the sale, the insider now owns 57,948 shares in the company, valued at $4,863,575.64. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. In other news, insider Jennifer Daniels sold 61,633 shares of Colgate-Palmolive stock in a transaction dated Thursday, February 1st. The shares were sold at an average price of $83.93, for a total value of $5,172,857.69. Following the completion of the transaction, the insider now owns 57,948 shares in the company, valued at $4,863,575.64. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CEO Noel R. Wallace sold 69,948 shares of the firm’s stock in a transaction that occurred on Tuesday, February 20th. The shares were sold at an average price of $84.22, for a total transaction of $5,891,020.56. Following the completion of the transaction, the chief executive officer now owns 286,881 shares of the company’s stock, valued at $24,161,117.82. The disclosure for this sale can be found here. Over the last three months, insiders have sold 232,371 shares of company stock valued at $19,505,099. Corporate insiders own 0.34% of the company’s stock.

Wall Street Analysts Forecast Growth

Several analysts have recently weighed in on the stock. UBS Group raised their price objective on shares of Colgate-Palmolive from $93.00 to $95.00 and gave the stock a “buy” rating in a report on Monday, January 29th. TheStreet raised shares of Colgate-Palmolive from a “c+” rating to a “b+” rating in a report on Friday, January 26th. StockNews.com lowered shares of Colgate-Palmolive from a “strong-buy” rating to a “buy” rating in a report on Tuesday, February 20th. Wells Fargo & Company increased their price target on shares of Colgate-Palmolive from $80.00 to $88.00 and gave the company an “equal weight” rating in a research note on Monday, January 29th. Finally, Barclays increased their price target on shares of Colgate-Palmolive from $75.00 to $82.00 and gave the company an “equal weight” rating in a research note on Tuesday, January 16th. Three analysts have rated the stock with a hold rating and twelve have given a buy rating to the company’s stock. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $87.31.

View Our Latest Stock Report on CL

About Colgate-Palmolive

(Free Report)

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.

See Also

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.